Master The Pharmacy Technician Certification Exam PTCE

Question 1

A vial of antibiotic for IM injection contains 1 g in 3 mL. What is the concentration in mg/mL?

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

The concentration in mg/mL is 333.33.

To find the concentration, we convert grams to milligrams and divide by the volume in milliliters. Since 1 g equals 1000 mg, we calculate 1000 mg divided by 3 mL, resulting in approximately 333.33 mg/mL.

A) 300
This option suggests a concentration of 300 mg/mL, which is incorrect. The calculation involves converting grams to milligrams and dividing by the volume; thus, 1000 mg divided by 3 mL does not yield 300 mg/mL.

B) 333.33
This is the correct choice, as it accurately represents the concentration calculated by dividing 1000 mg by 3 mL, resulting in 333.33 mg/mL.

C) 600
A concentration of 600 mg/mL is incorrect. If we were to reach this number, it would imply a higher total mass or a smaller volume than provided, which does not align with the given quantities of 1 g in 3 mL.

D) 666.66
This choice indicates a concentration of 666.66 mg/mL, which is also incorrect. This value would suggest an erroneous calculation or misinterpretation of the mass to volume ratio, exceeding the actual concentration derived from the provided figures.

Conclusion
The correct concentration of the antibiotic is determined to be 333.33 mg/mL, based on the conversion from grams to milligrams and the specified volume. The incorrect options stem from miscalculations or misunderstandings of the concentration formula, emphasizing the importance of precise unit conversion in such calculations.

Select an answer to continue →

Question 2

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is 30.

The iPLEDGE program mandates a maximum supply of 30 days for isotretinoin to ensure proper monitoring and safety during treatment, as isotretinoin can have significant side effects.

A) 7
A supply of 7 days is insufficient for effective treatment with isotretinoin and does not align with the guidelines established by iPLEDGE. This duration would not allow patients to achieve the necessary therapeutic levels for managing severe acne.

B) 30
This is the correct answer, as iPLEDGE explicitly stipulates that the maximum days' supply of isotretinoin allowed per fill is 30, allowing for adequate treatment while ensuring safety protocols are followed for monitoring patient health.

C) 60
A 60-day supply would exceed the limits set by iPLEDGE and could pose a risk to patient safety. Longer supplies could lead to a lack of necessary monitoring and increase the potential for severe adverse effects associated with isotretinoin.

D) 90
Providing a 90-day supply is not permitted under the iPLEDGE program, as it would significantly compromise the monitoring process crucial for patient safety. This extended duration could also increase the risk of misuse or adverse reactions without appropriate oversight.

Conclusion
The iPLEDGE program is designed to regulate isotretinoin usage due to its potential risks, establishing a maximum days' supply of 30 per fill. This limit facilitates necessary patient monitoring and minimizes the risk of severe side effects, ensuring that treatment remains both effective and safe. All other options exceed this guideline, highlighting the importance of adherence to established protocols in medication management.

Select an answer to continue →

Question 3

Which of the following medications must be transported and handled according to the guidelines found in USP Chapter 800?

Your Answer: Option(s)

Correct Answer: Option(s) D

Rationale

Anastrozole must be transported and handled according to the guidelines found in USP Chapter 800.

Anastrozole is classified as a hazardous drug, requiring specific handling and transportation procedures as outlined in USP Chapter 800. This chapter provides guidelines to ensure the safety of healthcare workers and patients when dealing with hazardous medications.

A) Acyclovir
Acyclovir is an antiviral medication used primarily for herpes simplex virus infections and is not classified as a hazardous drug. Therefore, it does not require the same stringent handling and transportation guidelines specified in USP Chapter 800.

B) Albuterol
Albuterol is a bronchodilator commonly used to treat asthma and other respiratory conditions. It is not considered a hazardous drug and does not fall under the regulations outlined in USP Chapter 800, which focuses on medications that pose risks to personnel handling them.

C) Amantadine
Amantadine is an antiviral medication used to treat and prevent influenza A and for Parkinson's disease. While it has specific safety considerations, it is not classified as a hazardous drug according to USP Chapter 800, thus exempting it from the chapter’s handling requirements.

D) Anastrozole
Anastrozole is an aromatase inhibitor used in the treatment of breast cancer and is classified as a hazardous drug. This categorization necessitates adherence to the guidelines of USP Chapter 800, which includes proper storage, handling, and disposal practices to minimize exposure risks.

Conclusion
Among the medications listed, only anastrozole is considered hazardous and must be managed according to USP Chapter 800 guidelines. The classification as a hazardous drug is critical for ensuring safety in handling and transporting, while the other options—acyclovir, albuterol, and amantadine—are not classified as hazardous and therefore do not require such stringent measures. Understanding these classifications is vital for promoting safety in medication management practices.

Select an answer to continue →

Question 4

A root-cause analysis (RCA) should be completed in the event of a:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

A root-cause analysis (RCA) should be completed in the event of a near miss.

A near miss represents a situation where an error was caught before it resulted in actual harm, making it crucial to conduct an RCA to identify underlying issues and prevent future occurrences.

A) Medication recall.
A medication recall typically arises from safety concerns about a specific product that has already been distributed. While recalls may require investigation, the focus is on the product itself rather than a systematic analysis of underlying causes related to errors or near misses.

B) Near miss.
Near misses provide valuable insights into potential risks in a system. Conducting an RCA in these scenarios helps organizations understand what went wrong and allows them to implement corrective measures before an actual error occurs, thereby enhancing patient safety and operational efficiency.

C) Predictable side effect.
Predictable side effects are typically known and documented outcomes of medication use that do not indicate system failures or errors. Since they are expected from the drug's pharmacological profile, they do not necessitate the same level of analysis as a near miss, which involves unexpected risks.

D) Drug utilization review.
A drug utilization review (DUR) is an evaluation process aimed at ensuring appropriate medication use and identifying potential problems in prescribing practices. While DURs contribute to medication safety, they are not specifically focused on analyzing incidents or errors such as near misses, thus not warranting an RCA.

Conclusion
Root-cause analysis is essential in the context of near misses to uncover systemic weaknesses that could lead to patient harm if unaddressed. By investigating near misses, healthcare organizations can proactively implement changes that enhance safety and prevent future errors, ultimately fostering a culture of continuous improvement in patient care.

Select an answer to continue →

Question 5

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to:

Your Answer: Option(s)

Correct Answer: Option(s) B

Rationale

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to fluoroquinolones.

Ciprofloxacin is a type of fluoroquinolone antibiotic. Patients allergic to one fluoroquinolone, such as ciprofloxacin, often exhibit hypersensitivity to other drugs within the same class due to structural similarities, necessitating caution in prescribing alternative fluoroquinolones.

A) macrolides.
Macrolides are a separate class of antibiotics that includes drugs like azithromycin and erythromycin. They have a different chemical structure and mechanism of action compared to fluoroquinolones. Therefore, an allergy to ciprofloxacin does not imply an allergy to macrolides.

B) fluoroquinolones.
Ciprofloxacin is a fluoroquinolone antibiotic, and hypersensitivity to it indicates a potential allergy to other drugs in the same class. This cross-reactivity is important to note in the patient's profile for safe prescribing practices, as exposure to other fluoroquinolones could trigger similar allergic reactions.

C) penicillins.
Penicillins are a distinct class of antibiotics, such as amoxicillin and penicillin G. The chemical structure of penicillins is notably different from that of fluoroquinolones, meaning that an allergy to ciprofloxacin does not suggest a corresponding allergy to penicillins.

D) sulfonamides.
Sulfonamides, including drugs like sulfamethoxazole, are another separate class of antibiotics with a different structure and mechanism. An allergy to ciprofloxacin does not indicate an allergy to sulfonamides, as they are not chemically related.

Conclusion
Patients with hypersensitivity to ciprofloxacin should be flagged for an allergy to fluoroquinolones due to the risk of cross-reactivity within this antibiotic class. Understanding the relationships between different antibiotic classes is crucial for ensuring patient safety and effective management of allergies in medical settings. Other antibiotic classes such as macrolides, penicillins, and sulfonamides do not share this risk, making it essential to accurately document and assess individual drug allergies in patient profiles.

Select an answer to continue →

Free Preview Ended

You've seen the first 5 questions.
Subscribe to unlock the remaining 85 questions + full features.

Unlock Full Exam See Other Exams

The concentration in mg/mL is 333.33.

According to iPLEDGE, the maximum days' supply of isotretinoin permitted per fill is 30.

Anastrozole must be transported and handled according to the guidelines found in USP Chapter 800.

A root-cause analysis (RCA) should be completed in the event of a near miss.

A patient who is hypersensitive to ciprofloxacin should have noted in their electronic profile that they are allergic to fluoroquinolones.

Free Preview Ended

Unlock Full Access

You are leaving this quiz

You're in the middle of a quiz

Report an Issue

Rate this Practice Test